Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.
Identifieur interne : 000206 ( Main/Exploration ); précédent : 000205; suivant : 000207Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.
Auteurs : Ulrike Theidel ; Alexander Kuhlmann ; Anja BraemSource :
- Deutsches Arzteblatt international [ 1866-0452 ] ; 2013.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Appréciation des risques (MeSH), Femelle (MeSH), Humains (MeSH), Infections communautaires (prévention et contrôle), Infections communautaires (épidémiologie), Infections à pneumocoques (prévention et contrôle), Infections à pneumocoques (épidémiologie), Jeune adulte (MeSH), Mâle (MeSH), Programmes nationaux de santé (statistiques et données numériques), Prévalence (MeSH), Répartition par sexe (MeSH), Répartition par âge (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccination de masse (statistiques et données numériques), Vaccins antipneumococciques (usage thérapeutique).
- MESH :
- prévention et contrôle : Infections communautaires, Infections à pneumocoques.
- statistiques et données numériques : Programmes nationaux de santé, Vaccination de masse.
- usage thérapeutique : Vaccins antipneumococciques.
- épidémiologie : Allemagne, Infections communautaires, Infections à pneumocoques.
- Adolescent, Adulte d'âge moyen, Appréciation des risques, Femelle, Humains, Jeune adulte, Mâle, Prévalence, Répartition par sexe, Répartition par âge, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Adolescent (MeSH), Age Distribution (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Community-Acquired Infections (epidemiology), Community-Acquired Infections (prevention & control), Female (MeSH), Germany (epidemiology), Humans (MeSH), Male (MeSH), Mass Vaccination (statistics & numerical data), Middle Aged (MeSH), National Health Programs (statistics & numerical data), Pneumococcal Infections (epidemiology), Pneumococcal Infections (prevention & control), Pneumococcal Vaccines (therapeutic use), Prevalence (MeSH), Risk Assessment (MeSH), Sex Distribution (MeSH), Young Adult (MeSH).
- MESH :
- chemical , therapeutic use : Pneumococcal Vaccines.
- epidemiology : Community-Acquired Infections, Germany, Pneumococcal Infections.
- prevention & control : Community-Acquired Infections, Pneumococcal Infections.
- statistics & numerical data : Mass Vaccination, National Health Programs.
- Adolescent, Age Distribution, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prevalence, Risk Assessment, Sex Distribution, Young Adult.
Abstract
BACKGROUND
The German Standing Committee on Vaccination Recommendations (Ständige Impfkommission, STIKO) recommends standard vaccination against pneumococcal infections for all persons aged 60 or older, and for all persons of any age with an increased health risk. It is not known how many persons in the target group in Germany have actually been vaccinated.
METHOD
We used claims data of a German statutory health insurance (Deutsche BKK) to determine pneumococcal vaccination rates, stratified by age and risk, for the one-year period 1 July 2008 to 30 June 2009. The number of influenza vaccinations in the same period was analyzed for comparison. Because pneumococcal vaccination does not need to be performed annually, the calculated rates are an underestimate of the percentage of persons who have been vaccinated. A simulation model was used to correct for persons vaccinated at earlier times. The vaccination rates were estimated on the basis of various scenarios.
RESULTS
Data were obtained on 867 683 persons aged 18 or older. According to an optimistic estimate, the percentage of pneumococcal vaccination in the overall population is 3.75% for persons aged 18-59 and 50.89% for persons aged 60 and above (influenza: 8.80% and 41.15%, respectively). In persons at elevated risk, the rate of vaccination in the presence of at least one risk factor is 12.66% / 54.67% (influenza: 15.66% / 39.96%). In persons with moderate risk, the vaccination rate is 16.02% / 56.75% (influenza: 18.54% / 40.61%); in persons whose elevated risk was high, it is 8.93% / 52.21% (influenza: 7.37%/37.78%). The limitations of this study are the short study period and the inability to define the population at risk unambiguously.
CONCLUSION
The rate of pneumococcal vaccination in adults in Germany is too low; at best, it is comparable to that of influenza vaccination. These results should be validated by nationwide monitoring of the pneumococcal vaccination program. For example, questions about pneumococcal vaccination could be included in the GEDA study (German Health Update) that is conducted annually by the Robert Koch Institute.
DOI: 10.3238/arztebl.2013.0743
PubMed: 24280430
PubMed Central: PMC3831240
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.</title><author><name sortKey="Theidel, Ulrike" sort="Theidel, Ulrike" uniqKey="Theidel U" first="Ulrike" last="Theidel">Ulrike Theidel</name><affiliation><nlm:affiliation>Herescon Gmbh, Hannover, Centre for Health Economics Research Hannover, Hannover, Department of Health Care Management, Deutsche BKK, Wolfsburg.</nlm:affiliation><wicri:noCountry code="subField">Wolfsburg</wicri:noCountry></affiliation></author><author><name sortKey="Kuhlmann, Alexander" sort="Kuhlmann, Alexander" uniqKey="Kuhlmann A" first="Alexander" last="Kuhlmann">Alexander Kuhlmann</name></author><author><name sortKey="Braem, Anja" sort="Braem, Anja" uniqKey="Braem A" first="Anja" last="Braem">Anja Braem</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24280430</idno><idno type="pmid">24280430</idno><idno type="doi">10.3238/arztebl.2013.0743</idno><idno type="pmc">PMC3831240</idno><idno type="wicri:Area/Main/Corpus">000178</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000178</idno><idno type="wicri:Area/Main/Curation">000178</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000178</idno><idno type="wicri:Area/Main/Exploration">000178</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.</title><author><name sortKey="Theidel, Ulrike" sort="Theidel, Ulrike" uniqKey="Theidel U" first="Ulrike" last="Theidel">Ulrike Theidel</name><affiliation><nlm:affiliation>Herescon Gmbh, Hannover, Centre for Health Economics Research Hannover, Hannover, Department of Health Care Management, Deutsche BKK, Wolfsburg.</nlm:affiliation><wicri:noCountry code="subField">Wolfsburg</wicri:noCountry></affiliation></author><author><name sortKey="Kuhlmann, Alexander" sort="Kuhlmann, Alexander" uniqKey="Kuhlmann A" first="Alexander" last="Kuhlmann">Alexander Kuhlmann</name></author><author><name sortKey="Braem, Anja" sort="Braem, Anja" uniqKey="Braem A" first="Anja" last="Braem">Anja Braem</name></author></analytic><series><title level="j">Deutsches Arzteblatt international</title><idno type="eISSN">1866-0452</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Age Distribution (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Community-Acquired Infections (epidemiology)</term><term>Community-Acquired Infections (prevention & control)</term><term>Female (MeSH)</term><term>Germany (epidemiology)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Mass Vaccination (statistics & numerical data)</term><term>Middle Aged (MeSH)</term><term>National Health Programs (statistics & numerical data)</term><term>Pneumococcal Infections (epidemiology)</term><term>Pneumococcal Infections (prevention & control)</term><term>Pneumococcal Vaccines (therapeutic use)</term><term>Prevalence (MeSH)</term><term>Risk Assessment (MeSH)</term><term>Sex Distribution (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Appréciation des risques (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections communautaires (prévention et contrôle)</term><term>Infections communautaires (épidémiologie)</term><term>Infections à pneumocoques (prévention et contrôle)</term><term>Infections à pneumocoques (épidémiologie)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Programmes nationaux de santé (statistiques et données numériques)</term><term>Prévalence (MeSH)</term><term>Répartition par sexe (MeSH)</term><term>Répartition par âge (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccination de masse (statistiques et données numériques)</term><term>Vaccins antipneumococciques (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Community-Acquired Infections</term><term>Germany</term><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Community-Acquired Infections</term><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections communautaires</term><term>Infections à pneumocoques</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Mass Vaccination</term><term>National Health Programs</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Programmes nationaux de santé</term><term>Vaccination de masse</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Infections communautaires</term><term>Infections à pneumocoques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Age Distribution</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Risk Assessment</term><term>Sex Distribution</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte d'âge moyen</term><term>Appréciation des risques</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Prévalence</term><term>Répartition par sexe</term><term>Répartition par âge</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The German Standing Committee on Vaccination Recommendations (Ständige Impfkommission, STIKO) recommends standard vaccination against pneumococcal infections for all persons aged 60 or older, and for all persons of any age with an increased health risk. It is not known how many persons in the target group in Germany have actually been vaccinated.</p></div><div type="abstract" xml:lang="en"><p><b>METHOD</b></p><p>We used claims data of a German statutory health insurance (Deutsche BKK) to determine pneumococcal vaccination rates, stratified by age and risk, for the one-year period 1 July 2008 to 30 June 2009. The number of influenza vaccinations in the same period was analyzed for comparison. Because pneumococcal vaccination does not need to be performed annually, the calculated rates are an underestimate of the percentage of persons who have been vaccinated. A simulation model was used to correct for persons vaccinated at earlier times. The vaccination rates were estimated on the basis of various scenarios.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Data were obtained on 867 683 persons aged 18 or older. According to an optimistic estimate, the percentage of pneumococcal vaccination in the overall population is 3.75% for persons aged 18-59 and 50.89% for persons aged 60 and above (influenza: 8.80% and 41.15%, respectively). In persons at elevated risk, the rate of vaccination in the presence of at least one risk factor is 12.66% / 54.67% (influenza: 15.66% / 39.96%). In persons with moderate risk, the vaccination rate is 16.02% / 56.75% (influenza: 18.54% / 40.61%); in persons whose elevated risk was high, it is 8.93% / 52.21% (influenza: 7.37%/37.78%). The limitations of this study are the short study period and the inability to define the population at risk unambiguously.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>The rate of pneumococcal vaccination in adults in Germany is too low; at best, it is comparable to that of influenza vaccination. These results should be validated by nationwide monitoring of the pneumococcal vaccination program. For example, questions about pneumococcal vaccination could be included in the GEDA study (German Health Update) that is conducted annually by the Robert Koch Institute.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24280430</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1866-0452</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>44</Issue><PubDate><Year>2013</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Deutsches Arzteblatt international</Title><ISOAbbreviation>Dtsch Arztebl Int</ISOAbbreviation></Journal><ArticleTitle>Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.</ArticleTitle><Pagination><MedlinePgn>743-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3238/arztebl.2013.0743</ELocationID><ELocationID EIdType="pii" ValidYN="Y">arztebl.2013.0743</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The German Standing Committee on Vaccination Recommendations (Ständige Impfkommission, STIKO) recommends standard vaccination against pneumococcal infections for all persons aged 60 or older, and for all persons of any age with an increased health risk. It is not known how many persons in the target group in Germany have actually been vaccinated.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We used claims data of a German statutory health insurance (Deutsche BKK) to determine pneumococcal vaccination rates, stratified by age and risk, for the one-year period 1 July 2008 to 30 June 2009. The number of influenza vaccinations in the same period was analyzed for comparison. Because pneumococcal vaccination does not need to be performed annually, the calculated rates are an underestimate of the percentage of persons who have been vaccinated. A simulation model was used to correct for persons vaccinated at earlier times. The vaccination rates were estimated on the basis of various scenarios.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were obtained on 867 683 persons aged 18 or older. According to an optimistic estimate, the percentage of pneumococcal vaccination in the overall population is 3.75% for persons aged 18-59 and 50.89% for persons aged 60 and above (influenza: 8.80% and 41.15%, respectively). In persons at elevated risk, the rate of vaccination in the presence of at least one risk factor is 12.66% / 54.67% (influenza: 15.66% / 39.96%). In persons with moderate risk, the vaccination rate is 16.02% / 56.75% (influenza: 18.54% / 40.61%); in persons whose elevated risk was high, it is 8.93% / 52.21% (influenza: 7.37%/37.78%). The limitations of this study are the short study period and the inability to define the population at risk unambiguously.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The rate of pneumococcal vaccination in adults in Germany is too low; at best, it is comparable to that of influenza vaccination. These results should be validated by nationwide monitoring of the pneumococcal vaccination program. For example, questions about pneumococcal vaccination could be included in the GEDA study (German Health Update) that is conducted annually by the Robert Koch Institute.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theidel</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Herescon Gmbh, Hannover, Centre for Health Economics Research Hannover, Hannover, Department of Health Care Management, Deutsche BKK, Wolfsburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhlmann</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Braem</LastName><ForeName>Anja</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Arztebl Int</MedlineTA><NlmUniqueID>101475967</NlmUniqueID><ISSNLinking>1866-0452</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch Arztebl Int. 2014 Apr 4;111(14):250</RefSource><PMID Version="1">24766713</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch Arztebl Int. 2014 Apr 4;111(14):250</RefSource><PMID Version="1">24766714</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24280430</ArticleId><ArticleId IdType="pii">arztebl.2013.0743</ArticleId><ArticleId IdType="doi">10.3238/arztebl.2013.0743</ArticleId><ArticleId IdType="pmc">PMC3831240</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaccine. 2009 Aug 6;27(36):4891-904</Citation><ArticleIdList><ArticleId IdType="pubmed">19520205</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2013 Feb 1;62(4):66-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23364272</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ Rev. 2012 Mar 30;2(1):4</Citation><ArticleIdList><ArticleId IdType="pubmed">22828176</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2008 Apr 1;46(7):1015-23</Citation><ArticleIdList><ArticleId IdType="pubmed">18444818</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2009 Dec;64(12):1062-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19454409</ArticleId></ArticleIdList></Reference><Reference><Citation>Orv Hetil. 2013 Jan 20;154(3):118-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23315227</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2008;5:52</Citation><ArticleIdList><ArticleId IdType="pubmed">18442371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Aug;50(8):1021-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17676419</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir Rev. 2012 Mar 1;21(123):57-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22379175</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010;340:c1004</Citation><ArticleIdList><ArticleId IdType="pubmed">20211953</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2008;(1):CD000422</Citation><ArticleIdList><ArticleId IdType="pubmed">18253977</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1992 Apr;14(4):801-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1576274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pneumologie. 2012 Aug;66(8):470-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22875730</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ Rev. 2011 Oct 04;1(1):16</Citation><ArticleIdList><ArticleId IdType="pubmed">22827933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Aug;50(8):1028-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17676417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesundheitswesen. 2010 Jun;72(6):316-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20480460</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 May 15;24(20):4378-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16574281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Jun 24;27(31):4136-41</Citation><ArticleIdList><ArticleId IdType="pubmed">19406190</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2012 Jan;67(1):71-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20729232</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Braem, Anja" sort="Braem, Anja" uniqKey="Braem A" first="Anja" last="Braem">Anja Braem</name><name sortKey="Kuhlmann, Alexander" sort="Kuhlmann, Alexander" uniqKey="Kuhlmann A" first="Alexander" last="Kuhlmann">Alexander Kuhlmann</name><name sortKey="Theidel, Ulrike" sort="Theidel, Ulrike" uniqKey="Theidel U" first="Ulrike" last="Theidel">Ulrike Theidel</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000206 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000206 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24280430
|texte= Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24280430" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |